Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Janssen - Advanced prostate cancer: How do we move forward in patient management?

Non metastatic castration resistant prostate cancer translating benefit to clinical practice & Choosing the right pathway in the current and future management of metastatic castration resistant prostate cancer

Date

14 Sep 2020

Session

Janssen - Advanced prostate cancer: How do we move forward in patient management?

Presenters

Nicolas Mottet

Authors

B.A. Hadaschik¹, K.N. Chi², E. Efstathiou³, N. Mottet⁴

Author affiliations

¹ Department Of Urology, University Hospital of Essen, 45147 - Essen/DE
² Medical Oncology Department, BC Cancer Agency - Vancouver, V5Z 4E6 - Vancouver/CA
³ The M. D. Anderson Cancer Center, 77030 - Houston/US
⁴ Uro-oncology Department, CHU Saint Etienne - Hopital Nord, 42055 - Saint-Étienne/FR

More

Resources

Login to access the resources on OncologyPRO.

Login

Resources from the same session

14 Sep 2020

Optimising care for individual patients with metastatic hormone sensitive prostate cancer

Presenter: Nicolas Mottet

Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?

Resources:

Webcast

14 Sep 2020

Flattening the curve: Consequences for the management of prostate cancer in the ongoing COVID-19 pandemic

Presenter: Boris Hadaschik

Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?

Resources:

Webcast

14 Sep 2020

Live Q&A - 18 September 2020 - 17:00-18:00

Presenter: Boris Hadaschik

Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?

Resources:

Webcast